ACUT - Accustem Sciences Inc.
0.38
-0.100 -26.289%
Share volume: 3,566
Last Updated: 03-27-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.18%
PREVIOUS CLOSE
CHG
CHG%
$0.48
-0.10
-0.21%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-20-2024 | 09-16-2024 | 11-18-2024 | 05-20-2025 | 11-12-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | |||
| Operating expenses | 526.602 K | 278.225 K | 328.174 K | 440.408 K | 399.897 K | |
| Selling general and admin | 503.405 K | 236.479 K | 296.765 K | 412.062 K | 327.177 K | |
| Research and development | 23.197 K | 41.746 K | 31.409 K | 28.346 K | 72.720 K | |
| Total expenses | 526.602 K | 278.225 K | 328.174 K | 440.408 K | 399.897 K | |
| -47.17% | 17.95% | 34.20% | -9.20% | |||
| Operating income | -526.602 K | -278.225 K | -328.174 K | -440.408 K | -399.897 K | |
| Ebit | -526.602 K | -278.225 K | -328.174 K | -440.408 K | -399.897 K | |
| Pretax income | -526.602 K | -278.225 K | -328.174 K | -440.408 K | -399.897 K | |
| -47.17% | 17.95% | 34.20% | -9.20% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -526.602 K | -278.225 K | -328.174 K | -440.408 K | -399.897 K | |
| 47.17% | -17.95% | -34.20% | 9.20% |